Early Detection Research Network (EDRN)

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Anderson, Karen S.	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-02	Wendy Wang, Ph.D., M.Sc.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.
Bresalier, Robert S	University Of Tx Md Anderson Can Ctr United States	Great Lakes New England Clinical Validation Center	5U01CA086400-23	Matthew Young, Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs	5U2CCA271895-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-03	Matthew Young, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	5U01CA152662-13	Guillermo Marquez, Ph.D.
Hanash, Samir M	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Lung Cancer Early Detection	5U01CA271888-03	Guillermo Marquez, Ph.D.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-07	Richard Mazurchuk, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-03	Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-03	Christos Patriotis, Ph.D., M.Sc.
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-03	Guillermo Marquez, Ph.D.
Li, Christopher I	Fred Hutchinson Cancer Center United States	Fred Hutchinson Breast Cancer Clinical Validation Center	5U01CA152637-14	Sidney Fu, M.D.
Maitra, Anirban	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	5U01CA200468-08	Matthew Young, Ph.D.
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-03	Matthew Young, Ph.D.

News and Events

Prevention and Screening Drive Drop in Cancer Deaths
Date Posted: January 14, 2025

DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024
Date Posted: March 12, 2024

Following Abnormal Cancer Screening Results, Multi-Level Reminders May Increase Follow-Up
Date Posted: December 22, 2023

Identifying New Biomarkers to Detect Lung Cancer Earlier
Date Posted: January 14, 2022